ABSTRACT
During the COVID-19 pandemic, more than 24 billion pieces of surgical mask waste (WM) were generated in the EU region, with an acute shortage of their management and recycling. Pyrolysis and gasification are among the most promising treatments that were proposed to dispose of WMs and convert them into pyrolysis oil and hydrogen-rich syngas. This work aimed to investigate the techno-economic analysis (TEA) of both treatments in order to assess the feasibility of scaling up. The TEA was carried out using a discounted cash flow model and its data were collected from practical experiments conducted using a fluidised bed pyrolysis reactor and bubbling fluidised bed gasifier system with a capacity of 0.2 kg/h and 1 kg/h, respectively, then upscaling to one tonne/h. The technological evaluation was made based on the optimal conditions that could produce the maximum amount of pyrolysis oil (42.3%) and hydrogen-rich syngas (89.7%). These treatments were also compared to the incineration of WMs as a commercial solution. The discounted payback, simple payback, net present value (NPV), production cost, and internal rate of return (IRR) were the main indicators used in the economic feasibility analysis. Sensitivity analysis was performed using SimLab software with the help of Monte Carlo simulations. The results showed that the production cost of the main variables was estimated at 45.4 EUR/t (gate fee), 71.7 EUR/MWh (electricity), 30.5 EUR/MWh (heat), 356 EUR/t (oil), 221 EUR/t (gaseous), 237 EUR/t (char), and 257 EUR/t (syngas). Meanwhile, the IRR results showed that gasification (12.51%) and incineration (7.56%) have better economic performance, while pyrolysis can produce less revenue (1.73%). Based on the TEA results, it is highly recommended to use the gasification process to treat WMs, yielding higher revenue. [ FROM AUTHOR] Copyright of Energies (19961073) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
ABSTRACT
The ongoing global pandemic of COVID-19 has devastatingly influenced the environment, society, and economy around the world. Numerous medical resources are used to inhibit the infectious transmission of the virus, resulting in massive medical waste. This study proposes a sustainable and environment-friendly method to convert hazardous medical waste into valuable fuel products through pyrolysis. Medical protective clothing (MPC), a typical medical waste from COVID-19, was utilized for co-pyrolysis with oil palm wastes (OPWs). The utilization of MPC improved the bio-oil properties in OPWs pyrolysis. The addition of catalysts further ameliorated the bio-oil quality. HZSM-5 was more effective in producing hydrocarbons in bio-oil, and the relevant reaction pathway was proposed. Meanwhile, a project was simulated to co-produce bio-oil and electricity from the co-pyrolysis of OPWs and MPC from application perspectives. The techno-economic analysis indicated that the project was economically feasible, and the payback period was 6.30-8.75 years. Moreover, it was also environmentally benign as its global warming potential varied from -211.13 to -90.76 kg CO2-eq/t. Therefore, converting MPC and OPWs into biofuel and electricity through co-pyrolysis is a green, economic, and sustainable method that can decrease waste, produce valuable fuel products, and achieve remarkable economic and environmental benefits.
ABSTRACT
The excessive usage of non-renewable resources to produce plastic commodities has incongruously influenced the environment's health. Especially in the times of COVID-19, the need for plastic-based health products has increased predominantly. Given the rise in global warming and greenhouse gas emissions, the lifecycle of plastic has been established to contribute to it significantly. Bioplastics such as polyhydroxy alkanoates, polylactic acid, etc. derived from renewable energy origin have been a magnificent alternative to conventional plastics and reconnoitered exclusively for combating the environmental footprint of petrochemical plastic. However, the economically reasonable and environmentally friendly procedure of microbial bioplastic production has been a hard nut to crack due to less scouted and inefficient process optimization and downstream processing methodologies. Thereby, meticulous employment of computational tools such as genome-scale metabolic modeling and flux balance analysis has been practiced in recent times to understand the effect of genomic and environmental perturbations on the phenotype of the microorganism. In-silico results not only aid us in determining the biorefinery abilities of the model microorganism but also curb our reliance on equipment, raw materials, and capital investment for optimizing the best conditions. Additionally, to accomplish sustainable large-scale production of microbial bioplastic in a circular bioeconomy, extraction, and refinement of bioplastic needs to be investigated extensively by practicing techno-economic analysis and life cycle assessment. This review put forth state-of-the-art know-how on the proficiency of these computational techniques in laying the foundation of an efficient bioplastic manufacturing blueprint, chiefly focusing on microbial polyhydroxy alkanoates (PHA) production and its efficacy in outplacing fossil based plastic products.
ABSTRACT
The need to increase the COVID-19 vaccine manufacturing capacity at low to middle-income countries (LMIC) led to a growing focus on Novavax (NVX-CoV2373), a thermostable protein subunit vaccine manufactured using a baculovirus and insect cell system (BICS) platform. This study aimed to conduct a techno-economic analysis to assess the BICS platform of vaccine manufacturing and compare it to the mRNA and the saRNA platform. The data from the Novavax patent for the COVID-19 vaccine formulation and the manufacturing steps were used to simulate the BICS vaccine production in SuperPro Designer. From the techno-economic analysis, the productivity of all platforms was compared in terms of doses/day per L production scale. The saRNA platform's productivity is about 1,000-fold of the BICS platform and 20-fold of the mRNA platform. BICS is a feasible option for LMIC to produce vaccines because the cost per dose is like the saRNA platform, while the mRNA platform's cost per dose is 7 times higher than the BICS and saRNA platforms. However, further optimization is necessary to improve the productivity of the BICS platform to match saRNA's platform. © 2022,International Journal of Technology.All Rights Reserved.
ABSTRACT
The pressing global challenges, including global warming and climate change, the Russia-Ukraine war, and the Covid-19 pandemic, all are indicative of the necessity of a transition from fossil-based systems toward bioenergy and bioproduct to ensure our plans for sustainable development. Such a transition, however, should be thoroughly engineered, considering the sustainability of the different elements of these systems. Advanced sustainability tools are instrumental in realizing this important objective. The present work critically reviews these tools, including techno-economic, life cycle assessment, emergy, energy, and exergy analyses, within the context of the bioenergy and bioproduct systems. The principles behind these methods are briefly explained, and then their pros and cons in designing, analyzing, and optimizing bioenergy and bioproduct systems are highlighted. Overall, it can be concluded that despite the promises held by these tools, they cannot be regarded as perfect solutions to address all the issues involved in realizing bioenergy and bioproduct systems, and integration of these tools can provide more reliable and accurate results than single approaches. © 2022 BRTeam. All rights reserved.
ABSTRACT
The widespread COVID-19 pandemic led to a shortage in the supply of N95 respirators in the United States until May 2021. In this study, we address the energy, environmental, and economic benefits of the decontamination-and-reuse of the N95 masks. Two popular decontamination methods, including dry heat and vapor hydrogen peroxide (VHP), are investigated in this study for their effective pathogen inactivation and favorable performance in preserving filtration efficiency and structural integrity of respirators. Two multiple reuse cases, under which the N95 masks are disinfected and used five times with the dry heat method and 20 times using the VHP method, are considered and compared with a single-use case. Compared to the single-use case, the dry heat-based multiple-use case reduces carbon footprint by 50% and cumulative energy demand (CED) by 17%, while the VHP-based case decreases carbon footprint by 67% and CED by 58%. The dry-heat-based and VHP-based multiple reuse cases also present environmental benefits in most of the other impact categories, primarily due to substituting new N95 respirators with decontaminated ones. Decontaminating and reusing respirators costs 77% and 89% less than the case of single-use and disposal. The sensitivity analysis results show that the geographical variation in the power grid and the times of respirator use are the most influential factors for carbon footprint and CED, respectively. The result also reaffirms the energy, environmental, and economic favorability of the decontamination and reuse of N95 respirators.
ABSTRACT
Combating the COVID-19 pandemic has raised the demand for and disposal of personal protective equipment in the United States. This work proposes a novel waste personal protective equipment processing system that enables energy recovery through producing renewable fuels and other basic chemicals. Exergy analysis and environmental assessment through a detailed life cycle assessment approach are performed to evaluate the energy and environmental sustainability of the processing system. Given the environmental advantages in reducing 35.42% of total greenhouse gas emissions from the conventional incineration and 43.50% of total fossil fuel use from landfilling processes, the optimal number, sizes, and locations of establishing facilities within the proposed personal protective equipment processing system in New York State are then determined by an optimization-based site selection methodology, proposing to build two pre-processing facilities in New York County and Suffolk County and one integrated fast pyrolysis plant in Rockland County. Their optimal annual treatment capacities are 1,708 t/y, 8,000 t/y, and 9,028 t/y. The proposed optimal personal protective equipment processing system reduces 31.5% of total fossil fuel use and 35.04% of total greenhouse gas emissions compared to the personal protective equipment incineration process. It also avoids 41.52% and 47.64% of total natural land occupation from the personal protective equipment landfilling and incineration processes.
ABSTRACT
To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA) and one self-amplifying RNA (saRNA) vaccines, all currently under clinical development, as well as for a hypothetical next-generation saRNA vaccine. The impact of key process design and operation uncertainties on the performance of the production process was assessed. The RNA vaccine drug substance (DS) production rates, volumes and costs are mostly impacted by the RNA amount per vaccine dose and to a lesser extent by the scale and titre in the production process. The resources, production scale and speed required to meet global demand vary substantially in function of the RNA amount per dose. For lower dose saRNA vaccines, global demand can be met using a production process at a scale of below 10 L bioreactor working volume. Consequently, these small-scale processes require a low amount of resources to set up and operate. RNA DS production can be faster than fill-to-finish into multidose vials; hence the latter may constitute a bottleneck.
ABSTRACT
The ongoing COVID-19 pandemic leads to a surge on consumption of respirators. This study proposes a novel and effective waste respirator processing system for protecting public health and mitigating climate change. Respirator sterilization and pre-processing technologies are included in the system to resist viral infection and facilitate unit processes for respirator pyrolysis, product separation, and downstream processing for greenhouse gas (GHG) emission reduction. We evaluate the system's environmental performance through high-fidelity process simulations and detailed life cycle assessment. Techno-economic analysis results show that the payback time of the waste respirator processing system is seven years with an internal rate of return of 21.5%. The tipping fee and discount rate are the most influential economic factors. Moreover, the unit life cycle GHG emissions from the waste respirator processing system are 12.93 kg CO2-eq per thousand waste respirators treated, which reduces GHG emissions by 59.08% compared to incineration-based system so as to mitigate climate change.